These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 38012210

  • 1. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y, Gong P, Su L, Zhang M.
    Sci Rep; 2023 Nov 27; 13(1):20870. PubMed ID: 38012210
    [Abstract] [Full Text] [Related]

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X.
    Front Immunol; 2022 Nov 27; 13():1056932. PubMed ID: 36479114
    [Abstract] [Full Text] [Related]

  • 3. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y, Zhao Q, Wu Y, Wang G, Huang Y, Sun W, Zhang M.
    Front Genet; 2022 Nov 27; 13():989719. PubMed ID: 36212154
    [Abstract] [Full Text] [Related]

  • 4. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y, Yao L, Man C, Gao Z, He R, Fan Y.
    Front Immunol; 2023 Nov 27; 14():1220760. PubMed ID: 37822927
    [Abstract] [Full Text] [Related]

  • 5. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL, Zhou DZ, Cao SJ, Li Q, Zhang JF, Xie H.
    Inflammation; 2022 Aug 27; 45(4):1732-1751. PubMed ID: 35322324
    [Abstract] [Full Text] [Related]

  • 6. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun 27; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 7. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y, Zhang Q, Zhang H, Kong F.
    Funct Integr Genomics; 2023 Jan 14; 23(1):38. PubMed ID: 36640225
    [Abstract] [Full Text] [Related]

  • 8. A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature.
    Zhang N, Yu X, Sun H, Zhao Y, Wu J, Liu G.
    Medicine (Baltimore); 2023 Oct 20; 102(42):e35167. PubMed ID: 37861553
    [Abstract] [Full Text] [Related]

  • 9. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
    Wang F, Lin H, Su Q, Li C.
    World J Surg Oncol; 2022 Sep 01; 20(1):275. PubMed ID: 36050740
    [Abstract] [Full Text] [Related]

  • 10. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma.
    Zhao Q, Ye Y, Zhang Q, Wu Y, Wang G, Gui Z, Zhang M.
    Biochem Biophys Rep; 2024 Mar 01; 37():101600. PubMed ID: 38371527
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C, Niu Y, Li F, Zhao W, Ma L.
    J Transl Med; 2022 Oct 05; 20(1):455. PubMed ID: 36199146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.
    Xu C, Chen A, Mao C, Cui B.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr 25; 52(2):139-147. PubMed ID: 37283097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X, Ye Z, Xiao G, He T.
    Comput Biol Med; 2023 Jun 25; 159():106905. PubMed ID: 37060773
    [Abstract] [Full Text] [Related]

  • 18. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
    Tu H, Zhang Q, Xue L, Bao J.
    Genes (Basel); 2022 Nov 25; 13(12):. PubMed ID: 36553481
    [Abstract] [Full Text] [Related]

  • 19. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma.
    Yu S, Tang L, Zhang Q, Li W, Yao S, Cai Y, Cheng H.
    Hereditas; 2023 Jul 24; 160(1):31. PubMed ID: 37482612
    [Abstract] [Full Text] [Related]

  • 20. Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma.
    Bai X, Lu F, Li S, Zhao Z, Wang N, Zhao Y, Ma G, Zhang F, Su X, Wang D, Ye J, Li P, Ji C.
    Sci Rep; 2024 Jun 05; 14(1):12926. PubMed ID: 38839842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.